Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares on July 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 31, 2024, Marc N. Casper, Chairman and CEO of Thermo Fisher Scientific, exercised stock options to acquire 10,000 shares of common stock at a price of $210.68 per share.
- Following the exercise of the options, Casper sold a total of 10,000 shares of common stock in multiple transactions at weighted average prices ranging from $612.55 to $620.12.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 10, 2023.
- After these transactions, Casper directly owns 123,816.462 shares of Thermo Fisher Scientific common stock.
- Casper also indirectly owns 11,300 shares through the Alison Casper 2020 Irrevocable Trust, 43,608 shares through Floral Park Associates, Inc., and 5,000 shares through the MNC 2020 Irrevocable Trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports transactions executed under a pre-existing plan. There's no inherent positive or negative implication.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which is generally viewed as a transparent and orderly way for insiders to sell shares.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, often used as part of compensation packages and personal financial planning. The use of Rule 10b5-1 plans is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Thermo Fisher Scientific is a large cap company in the life sciences and diagnostics industry.
- Executive compensation practices, including stock options and sales, are generally comparable to those of its peers such as Danaher, Agilent Technologies, and Roche.
- Rule 10b5-1 trading plans are widely used by executives in similar companies to manage their stock holdings.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider information being used.
Key Dates
| Date | Description |
|---|---|
| 2019-02-27 | First vesting date of the stock option in four equal installments. |
| 2020-02-27 | Second vesting date of the stock option in four equal installments. |
| 2021-02-27 | Third vesting date of the stock option in four equal installments. |
| 2022-02-27 | Fourth vesting date of the stock option in four equal installments. |
| 2023-11-10 | Date the Rule 10b5-1 trading plan was adopted. |
| 2024-07-31 | Date of stock option exercise and share sales. |
| 2025-02-27 | Expiration date of the stock option. |
| 2024-08-01 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.